thiamine has been researched along with Deafness in 36 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
Deafness: A general term for the complete loss of the ability to hear from both ears.
Excerpt | Relevance | Reference |
---|---|---|
" Thiamine-responsive megaloblastic anaemia (TRMA), due to mutations in the thiamine transporter SLC19A2, is associated with the classical clinical triad of diabetes, deafness, and megaloblastic anaemia." | 8.88 | Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. ( Abdullah, M; Ellard, S; Flanagan, SE; Grulich-Henn, J; Habeb, AM; Hattersley, AT; Hussain, K; Matyka, K; Patch, AM; Pomahacova, R; Shaw-Smith, C, 2012) |
"5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 8.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is the association of diabetes mellitus, anaemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein." | 7.73 | Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. ( Ariyawansa, I; Barrett, TG; Lo, IF; Minton, JA; Ricketts, CJ; Samuel, J; Wales, JK, 2006) |
"Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 7.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
"Thiamine-responsive megaloblastic anemia (TRMA, also known as Rogers syndrome, OMIM 249270) is a rare autosomal recessive disorder characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 7.70 | Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. ( Barrett, T; Cohen, N; Mandel, H; Neufeld, EJ; Nosaka, K; Raz, T; Szargel, R; Viana, MB, 1998) |
"We have investigated the cellular pathology of the syndrome called thiamine-responsive megaloblastic anemia (TRMA) with diabetes and deafness." | 7.70 | Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. ( Baker, MA; Cohen, N; Fleming, JC; Neufeld, EJ; Sakamoto, M; Stagg, AR, 1999) |
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA; MIM 249270) is an autosomal recessive disorder with features that include megaloblastic anaemia, mild thrombocytopenia and leucopenia, sensorineural deafness and diabetes mellitus." | 7.70 | Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. ( Banikazemi, M; Desnick, RJ; Diaz, GA; Gelb, BD; Oishi, K, 1999) |
"Thiamine-responsive megaloblastic anaemia (TRMA), also known as Rogers syndrome, is an early onset, autosomal recessive disorder defined by the occurrence of megaloblastic anaemia, diabetes mellitus and sensorineural deafness, responding in varying degrees to thiamine treatment (MIM 249270)." | 7.70 | Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. ( Baron, D; Barrett, T; Cohen, N; Gregory, S; Labay, V; Mandel, H; McDonald, L; Nosaka, K; Raz, T; Shalata, A; Szargel, R; Williams, H, 1999) |
"Thiamine-responsive megaloblastic anaemia with diabetes and deafness (TRMA; MIM 249270) is an autosomal recessive disease thought to be due to a defect in thiamine (vitamin B1) transport." | 7.70 | The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. ( Cohen, N; Fleming, JC; Neufeld, EJ; Schorderet, DF; Steinkamp, MP; Tartaglini, E, 1999) |
"Three brothers with diabetes mellitus, thiamine-responsive megaloblastic anemia, and sensorineural deafness are reported." | 7.67 | Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. ( Abboud, MR; Alexander, D; Najjar, SS, 1985) |
"Wolfram syndrome, Kearns-Sayre syndrome, thiamine-responsive megaloblastic anemia, and maternally inherited diabetes and deafness are genetic disorders characterized by diabetes, impaired hearing, and vision." | 5.22 | Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision. ( Gruber, N; Pinhas-Hamiel, O, 2022) |
" Thiamine-responsive megaloblastic anaemia (TRMA), due to mutations in the thiamine transporter SLC19A2, is associated with the classical clinical triad of diabetes, deafness, and megaloblastic anaemia." | 4.88 | Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. ( Abdullah, M; Ellard, S; Flanagan, SE; Grulich-Henn, J; Habeb, AM; Hattersley, AT; Hussain, K; Matyka, K; Patch, AM; Pomahacova, R; Shaw-Smith, C, 2012) |
"5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 4.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
"Individuals with thiamine-responsive megaloblastic anemia (TRMA) mainly manifest macrocytic anemia, sensorineural deafness, ocular complications, and nonautoimmune diabetes." | 4.31 | An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment. ( Arrigoni, F; Bonfanti, R; Di Candia, F; Di Iorio, V; Fedi, L; Franzese, A; Iafusco, F; Iovino, C; Malesci, R; Mozzillo, E; Rigamonti, A; Rosanio, FM; Simonelli, F; Tinto, N, 2023) |
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is the association of diabetes mellitus, anaemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein." | 3.73 | Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. ( Ariyawansa, I; Barrett, TG; Lo, IF; Minton, JA; Ricketts, CJ; Samuel, J; Wales, JK, 2006) |
"Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 3.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
"Thiamine-responsive megaloblastic anemia (TRMA, also known as Rogers syndrome, OMIM 249270) is a rare autosomal recessive disorder characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 3.70 | Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. ( Barrett, T; Cohen, N; Mandel, H; Neufeld, EJ; Nosaka, K; Raz, T; Szargel, R; Viana, MB, 1998) |
"We have investigated the cellular pathology of the syndrome called thiamine-responsive megaloblastic anemia (TRMA) with diabetes and deafness." | 3.70 | Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. ( Baker, MA; Cohen, N; Fleming, JC; Neufeld, EJ; Sakamoto, M; Stagg, AR, 1999) |
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA; MIM 249270) is an autosomal recessive disorder with features that include megaloblastic anaemia, mild thrombocytopenia and leucopenia, sensorineural deafness and diabetes mellitus." | 3.70 | Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. ( Banikazemi, M; Desnick, RJ; Diaz, GA; Gelb, BD; Oishi, K, 1999) |
"Thiamine-responsive megaloblastic anaemia (TRMA), also known as Rogers syndrome, is an early onset, autosomal recessive disorder defined by the occurrence of megaloblastic anaemia, diabetes mellitus and sensorineural deafness, responding in varying degrees to thiamine treatment (MIM 249270)." | 3.70 | Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. ( Baron, D; Barrett, T; Cohen, N; Gregory, S; Labay, V; Mandel, H; McDonald, L; Nosaka, K; Raz, T; Shalata, A; Szargel, R; Williams, H, 1999) |
"Thiamine-responsive megaloblastic anaemia with diabetes and deafness (TRMA; MIM 249270) is an autosomal recessive disease thought to be due to a defect in thiamine (vitamin B1) transport." | 3.70 | The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. ( Cohen, N; Fleming, JC; Neufeld, EJ; Schorderet, DF; Steinkamp, MP; Tartaglini, E, 1999) |
"Thiamine responsive megaloblastic anemia (TRMA) is an autosomal recessive disorder with a triad of symptoms: megaloblastic anemia, deafness, and non-type 1 diabetes mellitus." | 3.70 | The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. ( Anbinder, Y; Baron, D; Barrett, T; Baruchel, A; Cayuela, JM; Cohen, N; Labay, V; Mandel, H; Rabl, W; Raz, T; Szargel, R; Viana, MB, 2000) |
"We have investigated thiamine metabolism and transport in the erythrocytes of two patients from unrelated families with thiamine responsive megaloblastic anaemia associated with diabetes mellitus and sensorineural deafness." | 3.67 | Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia. ( Andria, G; De Vizia, B; Longo, G; Patrini, C; Poggi, V; Rindi, G, 1989) |
"Three brothers with diabetes mellitus, thiamine-responsive megaloblastic anemia, and sensorineural deafness are reported." | 3.67 | Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. ( Abboud, MR; Alexander, D; Najjar, SS, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (50.00) | 18.7374 |
1990's | 7 (19.44) | 18.2507 |
2000's | 6 (16.67) | 29.6817 |
2010's | 2 (5.56) | 24.3611 |
2020's | 3 (8.33) | 2.80 |
Authors | Studies |
---|---|
Gruber, N | 1 |
Pinhas-Hamiel, O | 1 |
Khaliq, S | 1 |
Di Candia, F | 1 |
Di Iorio, V | 1 |
Tinto, N | 1 |
Bonfanti, R | 1 |
Iovino, C | 1 |
Rosanio, FM | 1 |
Fedi, L | 1 |
Iafusco, F | 1 |
Arrigoni, F | 1 |
Malesci, R | 1 |
Simonelli, F | 1 |
Rigamonti, A | 1 |
Franzese, A | 2 |
Mozzillo, E | 1 |
Bergmann, AK | 1 |
Sahai, I | 1 |
Falcone, JF | 1 |
Fleming, J | 1 |
Bagg, A | 1 |
Borgna-Pignati, C | 1 |
Casey, R | 1 |
Fabris, L | 1 |
Hexner, E | 1 |
Mathews, L | 1 |
Ribeiro, ML | 1 |
Wierenga, KJ | 1 |
Neufeld, EJ | 5 |
Zhang, SQ | 1 |
Guan, YT | 1 |
Shaw-Smith, C | 1 |
Flanagan, SE | 1 |
Patch, AM | 1 |
Grulich-Henn, J | 1 |
Habeb, AM | 1 |
Hussain, K | 1 |
Pomahacova, R | 1 |
Matyka, K | 1 |
Abdullah, M | 1 |
Hattersley, AT | 1 |
Ellard, S | 1 |
OHZAWA, R | 1 |
NAKAMURA, M | 1 |
WILLIAMS, HL | 1 |
MAHER, FT | 1 |
CORBIN, KB | 1 |
BROWN, JR | 1 |
BROWN, HA | 1 |
HEDGECOCK, LD | 1 |
NAKAHARA, K | 1 |
MARUYAMA, R | 1 |
TAKENOUE, T | 1 |
GOTO, K | 1 |
SEKIYA, T | 1 |
WATANABE, T | 1 |
KANEKO, Z | 1 |
OSHITA, F | 1 |
NIWA, O | 1 |
YASUDA, Y | 1 |
NUMAKURA, M | 1 |
HONMA, T | 1 |
ONUMA, M | 1 |
OSAWA, R | 1 |
Davidson, A | 1 |
Hartley, PS | 1 |
Berman, P | 1 |
Shuttleworth, MH | 1 |
Ricketts, CJ | 1 |
Minton, JA | 1 |
Samuel, J | 1 |
Ariyawansa, I | 1 |
Wales, JK | 1 |
Lo, IF | 1 |
Barrett, TG | 1 |
Subramanian, VS | 1 |
Marchant, JS | 1 |
Said, HM | 1 |
TOMOMATU, S | 1 |
Haworth, C | 1 |
Evans, DI | 2 |
Mitra, J | 1 |
Wickramasinghe, SN | 1 |
Valerio, G | 1 |
Poggi, V | 2 |
Tenore, A | 1 |
Raz, T | 3 |
Barrett, T | 3 |
Szargel, R | 3 |
Mandel, H | 3 |
Nosaka, K | 2 |
Viana, MB | 3 |
Cohen, N | 5 |
Stagg, AR | 1 |
Fleming, JC | 3 |
Baker, MA | 1 |
Sakamoto, M | 1 |
Diaz, GA | 1 |
Banikazemi, M | 1 |
Oishi, K | 1 |
Desnick, RJ | 1 |
Gelb, BD | 1 |
Labay, V | 2 |
Baron, D | 2 |
Williams, H | 1 |
McDonald, L | 1 |
Shalata, A | 1 |
Gregory, S | 1 |
Tartaglini, E | 2 |
Steinkamp, MP | 2 |
Schorderet, DF | 1 |
Anbinder, Y | 1 |
Rabl, W | 1 |
Baruchel, A | 1 |
Cayuela, JM | 1 |
Gritli, S | 1 |
Omar, S | 1 |
Guannouni, S | 1 |
Berul, CI | 1 |
Hafsia, R | 1 |
Jilani, SB | 1 |
Belhani, A | 1 |
Hamdi, M | 1 |
Carvalho, RI | 1 |
Rindi, G | 1 |
Patrini, C | 1 |
De Vizia, B | 1 |
Longo, G | 1 |
Andria, G | 1 |
Abboud, MR | 1 |
Alexander, D | 1 |
Najjar, SS | 1 |
Ouchi, H | 1 |
Ishida, H | 1 |
Otani, I | 1 |
Mizuno, S | 1 |
Hattori, M | 1 |
Watanabe, Y | 1 |
Ozaki, M | 1 |
Naito, T | 1 |
Porter, FS | 1 |
Rogers, LE | 1 |
Sidbury, JB | 1 |
Hine, S | 1 |
Koike, Y | 1 |
3 reviews available for thiamine and Deafness
Article | Year |
---|---|
Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision.
Topics: Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hearing; Hearing Loss | 2022 |
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Topics: Anemia, Megaloblastic; Consanguinity; Deafness; Diabetes Mellitus; Genes, Recessive; Homozygote; Hum | 2012 |
Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.
Topics: Adolescent; Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Deafness; Diabetes Mellitus, Typ | 1998 |
33 other studies available for thiamine and Deafness
Article | Year |
---|---|
Thiamine responsive megaloblastic anaemia complicated with acute Parvovirus infection: A case report.
Topics: Adolescent; Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; | 2023 |
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
Topics: Adult; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Early Diagnosis; Hearing Loss, Sen | 2023 |
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
Topics: Adult; Anemia, Megaloblastic; Child; Child, Preschool; Cohort Studies; Deafness; Diabetes Mellitus; | 2009 |
Acute bilateral deafness as the first symptom of Wernicke encephalopathy.
Topics: Brain; Deafness; Humans; Magnetic Resonance Imaging; Male; Thiamine; Treatment Outcome; Wernicke Enc | 2012 |
[CLINICAL TRIAL OF NEUVITA IN THE TREATMENT OF NERVE DEAFNESS].
Topics: Deafness; Hearing Loss; Humans; Japan; Sulfides; Thiamine | 1963 |
ERIODICTYOL GLYCOSIDE IN THE TREATMENT OF MENI'ERE'S DISEASE.
Topics: Ascorbic Acid; Choline; Deafness; Flavanones; Flavonoids; Glycosides; Inositol; Meniere Disease; Met | 1963 |
[2 CASES OF SLIGHT PERCEPTIVE DEAFNESS CURED BY ASPARA TABLETS].
Topics: Aspartic Acid; Chondroitin; Deafness; Hearing Loss; Hearing Loss, Sensorineural; Humans; Tablets; Th | 1963 |
[CASE OF HERPES ZOSTER OTICUS ACCOMPANIED BY MULTIPLE CRANIAL NERVE PARALYSIS].
Topics: Adenosine Triphosphate; Arthritis; Arthritis, Rheumatoid; Arthroplasty; Cochlear Nerve; Cranial Nerv | 1964 |
[THERAPEUTIC RESULTS IN THE TREATMENT OF NERVE DEAFNESS WITH THE COMBINED USE OF NOIVITA AND VERINA].
Topics: Adenosine Triphosphate; Chondroitin; Deafness; Drug Therapy; Hearing Loss; Niacin; Nicotinic Acids; | 1964 |
[The use of sugarcoated alinamin in massive doses in the treatment of inner ear deafness and tinnitus aurium].
Topics: Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Sensorineural; Humans; Thiamine; Tinnitus | 1962 |
[Experience in the use of ATP-2Na (Adephos KOWA) in inner ear deafness and tinnitus].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Senso | 1962 |
[Results in biotamin treatment of perceptual deafness].
Topics: Deafness; Hearing Loss; Humans; Thiamine | 1962 |
Megaloblastic anaemia, diabetes and deafness in a 2-year-old child.
Topics: Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Female; Humans; Thiami | 2005 |
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Topics: Adolescent; Adult; Anemia, Megaloblastic; Child; Child, Preschool; Deafness; Diabetes Mellitus; DNA | 2006 |
Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines.
Topics: Anemia, Megaloblastic; Cell Line; Cytoplasm; Deafness; Diabetes Mellitus; DNA Mutational Analysis; F | 2007 |
[Methods of diagnosis of nervous deafness due to a lack of Vitamin B1, and results in the treatment of such a condition].
Topics: Deafness; Humans; Thiamine; Thiazoles | 1948 |
Thiamine responsive anaemia: a study of two further cases.
Topics: Anemia, Macrocytic; Bone Marrow; Child; Deafness; Deoxyuridine; Diabetes Mellitus; DNA; Erythroblast | 1982 |
Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity.
Topics: Anemia, Megaloblastic; Child; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 1; Deaf | 1998 |
Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.
Topics: Anemia, Megaloblastic; Apoptosis; Carrier Proteins; Cells, Cultured; Deafness; Diabetes Mellitus; Fi | 1999 |
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Topics: Amino Acid Sequence; Anemia, Megaloblastic; Base Sequence; Carrier Proteins; Cloning, Molecular; Dea | 1999 |
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Base Sequence; Carrier Proteins; Cricetinae; De | 1999 |
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Base Sequence; Carrier Proteins; Cell Line; Dea | 1999 |
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
Topics: Alleles; Anemia, Megaloblastic; Carrier Proteins; Deafness; Diabetes Mellitus; DNA Mutational Analys | 2000 |
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
Topics: Anemia, Megaloblastic; Bone Marrow Cells; Cardiomyopathy, Dilated; Carrier Proteins; Child, Preschoo | 2001 |
Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome?
Topics: Adult; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Diabetes Melli | 1978 |
Thiamine responsive anaemia.
Topics: Anemia; Deafness; Female; Humans; Thiamine; Thiamine Deficiency | 1991 |
Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia.
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Er | 1989 |
Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity.
Topics: Adolescent; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Child, Preschool; Deafness; Diabetes M | 1985 |
[Effects of vitamin B1 derivatives on the hearing disorders caused by kanamycin. 2].
Topics: Animals; Cochlea; Deafness; Kanamycin; Microscopy, Phase-Contrast; Rabbits; Thiamine | 1970 |
[Case of recurrent deafness without vertigo].
Topics: Acetazolamide; Adult; Deafness; Hearing Tests; Humans; Male; Thiamine; Vertigo | 1969 |
Thiamine-responsive megaloblastic anemia.
Topics: Amino Acids; Anemia, Macrocytic; Bone Marrow Examination; Child; Deafness; Diabetes Complications; D | 1969 |
[Thiamine disulfide-O, O'-bismonophosphate (VMT-908) in treatment of nerve deafness].
Topics: Deafness; Humans; Thiamine | 1965 |
[Thiamine disulfide bis-monophosphate in the field of otolaryngology].
Topics: Deafness; Facial Paralysis; Humans; Olfaction Disorders; Thiamine | 1966 |